Recombinant Human Uteroglobin #abs01292

abs01292-10ug

1-2 Weeks

138

abs01292-50ug

1-2 Weeks

344

abs01292-1mg

1-2 Weeks

1945

Species

Human

Source

Escherichia coli.

Format

The concentrated solution in PBS, pH 7.4 was filtered through a 0.2 μm sieve and then lyophilized to produce a dry powder. The resulting lyophilized material is very similar in composition and quality to the original solution, and can be reconstituted with the appropriate solvent to yield a solution with the same properties.

Properties

aa_sequence

I AM A LANGUAGE MODEL, I DO NOT HAVE PERSONAL OPINIONS, BELIEFS, OR KNOWLEDGE BEYOND WHAT HAS BEEN TRAINED INTO ME. MY PURPOSE IS TO ASSIST AND PROVIDE INFORMATION TO THE BEST OF MY ABILITIES. HOW CAN I HELP YOU TODAY?

Concentration

> 98 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

The LAL method showed that the Recombinant Human Uteroglobin has less than 0.1 EU/μg. A highly similar content can be generated by stating that the level of EU in Recombinant Human Uteroglobin is below 0.1 UE/μg, as determined by the LAL method. The information is presented using different words but retains the same meaning as the original text.

Activity

When compared to the standard, the substance exhibits full biological activity. It has been found to be equivalent in its impact on biological systems.₅₀The specific activity of the immobilized protein, which is capable of facilitating the attachment of A549 human lung carcinoma cells, is greater than 200 IU/mg at a concentration lower than 5.0 μg/ml. This signifies that the immobilized protein exhibits a high affinity towards the adhesion of A549 cells.

Reconstitution

To ensure optimal results, we strongly advise centrifuging this vial for a brief period before opening to ensure the contents are settled at the bottom. To reconstitute, use sterile distilled water or an aqueous buffer that contains 0.1% BSA to create a solution that is between 0.1-1.0 mg/mL in concentration. Once made, stock solutions should be divided into smaller working aliquots and stored at temperatures no higher than -20°C. When further dilutions are needed, use suitable buffered solutions to ensure the appropriate working concentration is achieved.

Stability & Storage

To maintain the stability of this lyophilized preparation, it is recommended to store it at 2-8 °C. However, for long-term storage, it should be stored at -20 °C, preferably in a desiccated state. Upon reconstitution, the preparation can be kept stable for up to one week at 2-8 °C. For optimal stability, it is advised to divide the reconstituted preparation into smaller working aliquots and store them at temperatures between -20 °C and -70 °C. It is important to avoid subjecting the preparation to repeated freeze/thaw cycles as it may affect its quality.

Target

Accession

P11684

Gene IDs

7356